Cherry Hill, NJ, United States of America

Neville Lewis Holder

This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neville Lewis Holder. Retrieved from https://idiyas.com/inventor/neville-lewis-holder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Neville Lewis Holder

Introduction

Neville Lewis Holder is a notable inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on novel compounds and processes that have the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents is the invention titled 'N-T-butyl-androst-3-5-diene-17 .beta.-carboxamide-3-carboxylic acid - Polymorph 'A'. This patent describes a novel polymorphic form of N-t-butyl-androst-3,5-diene-17.beta.-carboxamide-3-carboxylic acid, along with innovative processes for preparing polymorph 'A'. These advancements could lead to improved formulations and applications in medicine.

Career Highlights

Neville Holder has built a successful career at SmithKline Beecham Corporation, where he has been instrumental in developing new pharmaceutical products. His expertise in polymorphic forms and their preparation processes has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Neville has collaborated with several esteemed colleagues, including Neil Howard Baine and Donald Nathaniel Klein. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Neville Lewis Holder's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…